AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
Xenter, Inc. raises $58.25 million in Series B financing to accelerate the commercial launch of its TechMed platform. This funding will also support innovation in wireless medical devices and technologies.
Amount Raised
$58.3 Million
Round Type
Series B
DraperBiotechnologyHealthcareDescription
Xenter, Inc., a leader in healthcare intelligence, successfully closed its Series B financing on June 30th, raising a total of $58.25 million. The round included existing shareholders and prominent healthcare investors. The funds will be used for commercial launch, technology development, and regulatory initiatives for Xenter's TechMed platform. This financing underlines the growing interest in Xenter's capabilities in capturing and utilizing healthcare data.
Fundz sees it the moment XENTER raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
Based on industry dataXENTER raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.